RxSight, Inc. (RXST)

62,37 +0,01 (+0,01%) Ab 12:20PM EDT. Markt geöffnet.

RxSight, Inc.

100 Columbia
Aliso Viejo, CA 92656
United States
949 521 7830
https://www.rxsight.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 374

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Ronald M. Kurtz M.D.	President, CEO & Director	1,21M	N/A	1963
Ms. Shelley B. Thunen	Chief Financial Officer	762,22k	N/A	1954
Dr. Ilya Goldshleger Ph.D.	Chief Operating Officer	761,46k	N/A	1975
Mr. Eric J. Weinberg	Chief Commercial Officer	762,74k	N/A	1961
Ms. Rebecca Williston	Vice President of Accounting & Finance	N/A	N/A	N/A
Mr. Matt Haller Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Mr. Oliver Moravcevic	Vice President of Investor Relations	N/A	N/A	N/A
Mr. Roy Freeman	Vice President of Marketing	N/A	N/A	N/A
Ms. Caroline Vaughn	Vice President of Human Resources	N/A	N/A	N/A
Mr. Scott Gaines	Senior VP of Commercial Operations & Business Process	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Corporate Governance

RxSight, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 7. Die grundlegenden Scores sind Audit: 5, Vorstand: 4, Shareholderrechte: 8, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.